ALOX15 and asthma: In humans, the enzymatic activity of 15-LOX, an ortholog of the mouse 12/15-LOX, was reduced in severe asthma, implying that 15-LOX-derived SPMs contribute towards the pathogenesis of chronic eosinophilic inflammation in severe asthma (14).